[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Paradise Entertainment Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Paradise Entertainment Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Parenteral Drug (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Parenteral Drug (India) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Parexel International Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Parexel International Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Patheon Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Patheon Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Patrys Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Patrys Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PCAS SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PCAS SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PCI Biotech Holding ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PCI Biotech Holding ASA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PDL BioPharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PDL BioPharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pegasus Pharmaceutical Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pegasus Pharmaceutical Company Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Peregrine Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Peregrine Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PerkinElmer Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PerkinElmer Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pernix Therapeutics Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pernix Therapeutics Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Perrigo Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Perrigo Co. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pfizer Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pfizer Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pfizer Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pfizer Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Phaarmasia Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phaarmasia Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharma Foods International Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharma Foods International Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharma-Bio Serv, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharma-Bio Serv, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmaceutical Product Development Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmaceutical Product Development Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmacyclics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmacyclics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmagap Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmagap Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmaids Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmaids Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PharmaLundensis AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PharmaLundensis AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PharmaNet Group Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PharmaNet Group Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 70 pages

Pharmasset, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmasset, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PharmAthene, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PharmAthene, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmaust Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmaust Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmaxis Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmaxis Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmesis International Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmesis International Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharming Group N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharming Group N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmos Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmos Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PharmswellBio Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PharmswellBio Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pharmsynthez Open Joint Stock Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmsynthez Open Joint Stock Company Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Phosphagenics Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phosphagenics Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PhotoCure ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PhotoCure ASA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Phylogica Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phylogica Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Physiomics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Physiomics plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PhytoHealth Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PhytoHealth Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PhytoMedical Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PhytoMedical Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Phytopharm plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phytopharm plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pierrel S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pierrel S.p.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pilot Therapeutics Holdings Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pilot Therapeutics Holdings Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Piramal Enterprises Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Piramal Enterprises Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Piramal Phytocare Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Piramal Phytocare Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Plethico Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Plethico Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Plethora Solutions Holdings PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Plethora Solutions Holdings PLC Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Pluristem Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pluristem Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Polo Biology Global Group Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Polo Biology Global Group Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Polydex Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Polydex Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

PolyMedix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PolyMedix, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers